| [1] |
Mrejen S， Sarraf D， Mukkamala SK， et al. Multimodal imaging of pigment epithelial detachment： a guide to evaluation[J]. Retina，2013，33（9）：1735-1762.
|
| [2] |
Moore DJ， Hussain AA， Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane[J]. Invest Ophthalmol Vis Sci，1995，36（7）：1290-1297.
|
| [3] |
Starita C， Hussain AA， Patmore A， et al. Localization of the site of major resistance to fluid transport in Bruch′s membrane[J]. Invest Ophthalmol Vis Sci，1997，38（3）：762-767.
|
| [4] |
Huang JD， Presley JB， Chimento MF， et al. Age-related changes in human macular Bruch′s membrane as seen by quick-freeze/deep-etch[J]. Exp Eye Res，2007，85（2）：202-218.
|
| [5] |
Ambati J， Fowler BJ. Mechanisms of age-related macular degeneration[J]. Neuron，2012，75（1）：26-39.
|
| [6] |
Marshall GE， Konstas AG， Reid GG， et al. Collagens in the aged human macula[J]. Graefes Arch Clin Exp Ophthalmol，1994，232（3）：133-140.
|
| [7] |
Cukras C， Agrón E， Klein ML， et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration： age-related eye disease study report No. 28[J]. Ophthalmology，2010，117（3）：489-499.
|
| [8] |
Stefansson E， Geirsdottir A， Sigurdsson H. Metabolic physiology in age related macular degeneration[J]. Prog Retin Eye Res，2011，30（1）：72-80.
|
| [9] |
Pepple K， Mruthyunjaya P. Retinal pigment epithelial detachments in age-related macular degeneration： classification and therapeutic options[J]. Semin Ophthalmol，2011，26（3）：198-208.
|
| [10] |
Fine SL， Hawkins B， Maguire M. Macular photocoagulation study[J]. Arch Ophthalmol，1984，102（11）：1583.
|
| [11] |
Cackett P， Htoon H， Wong D， et al. Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population[J]. Eye （Lond），2010，24（5）：789-792.
|
| [12] |
Iijima H， Iida T， Imai M， et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol，2000， 129（1）：21-26.
|
| [13] |
Braunstein RA， Gass JD. Serous detachments of the retinal pigment epithelium in patients with senile macular disease[J]. Am J Ophthalmol，1979，88（4）：652-660.
|
| [14] |
Lommatzsch A， Heimes B， Gutfleisch M， et al. Serous pigment epithelial detachment in age-related macular degeneration： comparison of different treatments[J]. Eye （Lond），2009，23（12）：2163-2168.
|
| [15] |
Gross-Jendroska M， Flaxel CJ， Schwartz SD， et al. Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection[J]. Aust N Z J Ophthalmol，1998，26（4）：311-317.
|
| [16] |
Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration： two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2[J]. Am J Ophthalmol，2001，131（5）：541-560.
|
| [17] |
Ladas ID， Kotsolis AI， Rouvas AA， et al. Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment[J]. Ophthalmologica，2007，221（5）：313-319.
|
| [18] |
Rosenfeld PJ， Brown DM， Heier JS， et al. Ranibizumab for neovascular age-related macular degeneration[J]. N Engl J Med，2006，355（14）：1419-1431.
|
| [19] |
Arora S， McKibbin M. One-year outcome after intravitreal ranibizumab for large， serous pigment epithelial detachment secondary to age-related macular degeneration[J]. Eye （Lond），2011，25（8）：1034-1038.
|
| [20] |
Patel KH， Chow CC， Rathod R， et al. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab[J]. Eye （Lond），2013，27（5）：663-668.
|
| [21] |
Age-Related Eye Disease Study 2 Research G. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration： The Age-Related Eye Disease Study 2 （AREDS2） randomized clinical trial[J]. JAMA，2013，309（19）：2005-2015.
|
